ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
62 899,53
-1,32%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ARCA Biopharma Inc (ABIO)

  7. ARCA Biopharma Inc (ABIO) Actualités

ABIO

ARCA Biopharma (ABIO)

ARCA Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ABIO
DateHeureSourceTitreSymboleSociété
25/04/202422h15GlobeNewswire Inc.ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
05/04/202419h09PR Newswire (US)Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
03/04/202413h30GlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
07/02/202419h08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABIOARCA Biopharma Inc
06/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
01/02/202422h35GlobeNewswire Inc.ARCA biopharma Announces 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
01/02/202422h15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABIOARCA Biopharma Inc
01/02/202400h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
19/12/202322h25Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ABIOARCA Biopharma Inc
19/12/202322h20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ABIOARCA Biopharma Inc
19/12/202322h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABIOARCA Biopharma Inc
18/10/202322h25GlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
18/10/202322h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
11/09/202322h01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABIOARCA Biopharma Inc
21/07/202322h25GlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
24/04/202322h36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
24/04/202322h25GlobeNewswire Inc.ARCA biopharma Announces First Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
24/04/202322h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABIOARCA Biopharma Inc
24/02/202322h22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ABIOARCA Biopharma Inc
24/02/202322h20GlobeNewswire Inc.ARCA biopharma Announces 2022 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
19/12/202222h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABIOARCA Biopharma Inc
19/12/202222h18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ABIOARCA Biopharma Inc
19/12/202222h05GlobeNewswire Inc.James Flynn Joins ARCA biopharma Board of DirectorsNASDAQ:ABIOARCA Biopharma Inc
03/11/202221h26Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ABIOARCA Biopharma Inc
03/11/202221h19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ABIOARCA Biopharma Inc
28/10/202222h15GlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2022 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
02/08/202222h15GlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2022 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
08/07/202222h31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ABIOARCA Biopharma Inc
21/06/202222h05GlobeNewswire Inc.Jacob Ma-Weaver Joins ARCA biopharma Board of DirectorsNASDAQ:ABIOARCA Biopharma Inc
05/05/202222h15GlobeNewswire Inc.ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options ReviewNASDAQ:ABIOARCA Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABIO

Dernières Valeurs Consultées

EU
HO
Thales
FTSE
UKX
FTSE 100
NASDAQ
MSFT
Microsoft
EU
GLE
Societe Generale
NASDAQ
NVDA
NVIDIA
EU
BN
Danone
EU
ORA
Orange
EU
AI
Air Liquide
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
EU
SGO
Cie de SaintGobain
USI
USTECH100
US Tech 100
EU
EN
Bouygues
EU
BEL20
Bel 20
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés